Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Chamaecyparis obtusa leaf extract
- Development stage
- Preclinical
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Topical, Oral
01
Overview
Chamaecyparis obtusa leaf extract, derived from the Japanese cypress (Hinoki), is a botanical ingredient containing bioactive compounds such as flavonoids (amentoflavone, ginkgetin), terpenes, and phytoncides. It is primarily utilized in cosmetic and topical formulations for its anti-inflammatory, antioxidant, and antimicrobial properties. Research indicates that the extract may inhibit STAT3 and JAK/STAT signaling pathways, suggesting potential therapeutic applications in inflammatory skin conditions and certain cancers, including breast and colorectal cancer. While investigated in research settings, it is not currently an approved pharmaceutical drug for these indications.
- Other names
- Chamaecyparis obtusa leaf extractJapanese cypress leaf extractHinoki leaf extract
02
Targets
mTOR (Mammalian target of rapamycin kinase)AKT (RAC-alpha serine/threonine-protein kinase)STAT3 (Signal Transducer and Activator of Transcription 3)JNK (Mitogen-activated protein kinase kinase kinase family)
Beyond the preview
Go deeper on Chamaecyparis obtusa leaf extract.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Chamaecyparis obtusa leaf extract.